These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35293206)

  • 21. Contribution of linker stability to the activities of anticancer immunoconjugates.
    Alley SC; Benjamin DR; Jeffrey SC; Okeley NM; Meyer DL; Sanderson RJ; Senter PD
    Bioconjug Chem; 2008 Mar; 19(3):759-65. PubMed ID: 18314937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody-Drug Conjugates.
    Kasper MA; Stengl A; Ochtrop P; Gerlach M; Stoschek T; Schumacher D; Helma J; Penkert M; Krause E; Leonhardt H; Hackenberger CPR
    Angew Chem Int Ed Engl; 2019 Aug; 58(34):11631-11636. PubMed ID: 31250955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
    Burke PJ; Hamilton JZ; Jeffrey SC; Hunter JH; Doronina SO; Okeley NM; Miyamoto JB; Anderson ME; Stone IJ; Ulrich ML; Simmons JK; McKinney EE; Senter PD; Lyon RP
    Mol Cancer Ther; 2017 Jan; 16(1):116-123. PubMed ID: 28062707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minireview: Addressing the retro-Michael instability of maleimide bioconjugates.
    Szijj PA; Bahou C; Chudasama V
    Drug Discov Today Technol; 2018 Dec; 30():27-34. PubMed ID: 30553517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab.
    Sijbrandi NJ; Merkul E; Muns JA; Waalboer DC; Adamzek K; Bolijn M; Montserrat V; Somsen GW; Haselberg R; Steverink PJ; Houthoff HJ; van Dongen GA
    Cancer Res; 2017 Jan; 77(2):257-267. PubMed ID: 27872093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody-Drug Conjugates.
    Matsuda Y; Seki T; Yamada K; Ooba Y; Takahashi K; Fujii T; Kawaguchi S; Narita T; Nakayama A; Kitahara Y; Mendelsohn BA; Okuzumi T
    Mol Pharm; 2021 Nov; 18(11):4058-4066. PubMed ID: 34579528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies.
    Renault K; Fredy JW; Renard PY; Sabot C
    Bioconjug Chem; 2018 Aug; 29(8):2497-2513. PubMed ID: 29954169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma.
    Wei C; Zhang G; Clark T; Barletta F; Tumey LN; Rago B; Hansel S; Han X
    Anal Chem; 2016 May; 88(9):4979-86. PubMed ID: 27075639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation.
    Christie RJ; Tiberghien AC; Du Q; Bezabeh B; Fleming R; Shannon A; Mao S; Breen S; Zhang J; Zhong H; Harper J; Wu H; Howard PW; Gao C
    Antibodies (Basel); 2017 Nov; 6(4):. PubMed ID: 31548535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers.
    St Amant AH; Lemen D; Florinas S; Mao S; Fazenbaker C; Zhong H; Wu H; Gao C; Christie RJ; Read de Alaniz J
    Bioconjug Chem; 2018 Jul; 29(7):2406-2414. PubMed ID: 29932647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-Specific Conjugation of Thiol-Reactive Cytotoxic Agents to Nonnative Cysteines of Engineered Monoclonal Antibodies.
    Dickgiesser S; Kellner R; Kolmar H; Rasche N
    Methods Mol Biol; 2019; 2033():1-14. PubMed ID: 31332743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
    Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
    ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies.
    Jendryczko K; Rzeszotko J; Krzyscik MA; Kocyła A; Szymczyk J; Otlewski J; Szlachcic A
    Mol Pharm; 2022 May; 19(5):1422-1433. PubMed ID: 35389227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel trastuzumab-DM1 conjugate: Synthesis and bio-evaluation.
    Abedi M; Cohan RA; Mahboudi F; Faramarzi MA; Fazel R; Damavandi N; Ardestani MS; Davami F
    J Cell Physiol; 2019 Aug; 234(10):18206-18213. PubMed ID: 30854662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
    Kumar A; Mao S; Dimasi N; Gao C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates.
    Davydova M; Dewaele Le Roi G; Adumeau P; Zeglis BM
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions.
    Ferraro E; Drago JZ; Modi S
    Breast Cancer Res; 2021 Aug; 23(1):84. PubMed ID: 34380530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide.
    Hervé-Aubert K; Allard-Vannier E; Joubert N; Lakhrif Z; Alric C; Martin C; Viaud-Massuard MC; Dimier-Poisson I; Aubrey N; Chourpa I
    Bioconjug Chem; 2018 May; 29(5):1553-1559. PubMed ID: 29553717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
    Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D
    PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.